About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.
A presidential debate, GLP-1s for kids, and ultra-processed foods research
Good morning! Today STAT is publishing the final installment in the “Embedded Bias” series. My colleagues Usha and Katie have done some amazing reporting over